Vaxart, Inc. (VXRT)
- 2023-03-24 16:00:05
- Nasdaq Real Time Price
Last0.76 +0.01 (+0.89%)
0.7 - 5.32
52 Week Range
Technical Indicators (Daily)
Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection.
Vaxart, Inc. (NASDAQ:VXRT) Q4 2022 Earnings Call Transcript
Vaxart, Inc. (NASDAQ:VXRT) Q4 2022 Earnings Call Transcript March 15, 2023 Operator: Greetings. Welcome to Vaxart Business Update and Full Year 2022 Financial Results Conference Call. A question-and-a...
Vaxart to Host Webcast with Key Opinion Leaders to Discuss the Health Impact and Disease Burden for Norovirus
Company to provide a detailed overview of its norovirus clinical program Webcast to be held on March 28, 2023 at 1:00 p.m. ET SOUTH SAN FRANCISCO, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- Vaxart, In...
Vaxart Provides Business Update and Full Year 2022 Financial Results
Prioritizing oral bivalent norovirus candidate, one of the most advanced norovirus vaccines in development Will continue preclinical development of novel COVID-19 vaccine constructs to enhance cross-r...
Vaxart to Host Full Year 2022 Business Update and Financial Results Conference Call on March 15
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financ...
Vaxart Doses First Subject in the Phase 2 Clinical Trial of its Bivalent Norovirus Candidate
Study to evaluate safety and immunogenicity of oral norovirus vaccine in healthy adults SOUTH SAN FRANCISCO, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that ...
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.